Hepatitis C is one of the most common bloodborne infections in the United States — and a large number of people carrying it have no idea. The virus can quietly damage the liver for years without producing symptoms you’d notice. By the time fatigue, jaundice, or abdominal pain appear, significant liver injury may already be present. The good news is that Hepatitis C is now curable in most cases with a short course of oral medication, and getting tested has never been more accessible for Knoxville and East Tennessee residents.
LifeLine Health Tennessee offers no-cost, confidential Hepatitis C testing and treatment to anyone in Tennessee regardless of insurance status or income. Everything happens through telehealth — meaning you can start the process from your home in Knoxville, Maryville, Oak Ridge, or anywhere else in East Tennessee without driving to a clinic or sitting in a waiting room.
How Hepatitis C Spreads — and Why So Many People Don’t Know They Have It
Hepatitis C virus (HCV) is transmitted when blood from an infected person enters another person’s bloodstream. The most common route today is sharing needles, syringes, or other equipment used to inject drugs [source:1]. But transmission can also happen through:
- Sharing personal items like razors or nail clippers that may carry trace amounts of blood
- Needlestick injuries in healthcare settings
- Receiving a blood transfusion or organ transplant before 1992, when widespread HCV screening of the blood supply began [source:2]
- Sexual contact, particularly when blood is present — though this route is less common [source:1]
- Birth to a mother with HCV (perinatal transmission) [source:1]
The reason so many infections go undetected is straightforward: the acute phase of HCV infection is often silent. Studies suggest that roughly 70 to 80 percent of newly infected people experience no symptoms at all [source:3]. Even as the infection becomes chronic — defined as lasting more than six months — most people continue to feel well for years or even decades. The liver has significant reserve capacity, and early damage rarely produces warning signs you can feel.
This is why testing is the only reliable way to know your status. Feeling healthy is not evidence that you’re HCV-negative.
Who Should Be Screened for Hepatitis C
The U.S. Preventive Services Task Force (USPSTF) recommends HCV screening for all adults aged 18 to 79 years — not just people with known risk factors [source:4]. That recommendation reflects how widespread undetected infection actually is in the general population.
Certain groups carry a higher likelihood of infection and should be screened regardless of age:
- People who currently inject drugs or have injected drugs at any point in the past
- Anyone who received a blood transfusion, clotting factor concentrates, or an organ transplant before July 1992 [source:2]
- People born between 1945 and 1965 — a generation sometimes called the “baby boomer” cohort, which has disproportionately high HCV prevalence [source:5]
- People who are HIV-positive [source:1]
- People who have been incarcerated
- Pregnant women — the CDC now recommends screening during each pregnancy [source:6]
- Healthcare workers with known or suspected needlestick exposures
If you’re unsure whether your history puts you at risk, the safest approach is simply to get tested. A single blood draw can answer the question definitively, and LifeLine Health’s process is designed to make that as easy as possible.
The Two-Step Testing Process Explained
HCV testing follows a two-step sequence. Understanding both steps helps you make sense of your results and know what to expect next.
Step One: The Antibody Test
The first test looks for HCV antibodies — proteins your immune system produces in response to exposure to the virus. A reactive (positive) antibody result means your body has encountered HCV at some point. It does not, by itself, confirm that you currently have an active infection [source:7].
There’s an important nuance here. Once your immune system produces HCV antibodies, they remain in your blood for life — even if the infection was cleared, either naturally or through treatment. So a reactive antibody test in someone who was successfully treated years ago does not mean the virus is back.
Step Two: The RNA Test (Viral Load)
If your antibody test is reactive, the next step is an HCV RNA test — sometimes called a viral load test or PCR test. This test detects the actual genetic material of the virus in your blood [source:7]. A detectable RNA result confirms active infection and provides a baseline viral load that helps guide treatment. An undetectable RNA result after a reactive antibody test typically means the infection resolved on its own at some point in the past.
About 15 to 25 percent of people who contract HCV clear the virus spontaneously without treatment [source:3]. If that applies to you, no further treatment is needed — though your provider may still want to monitor liver health.
What Your Results Mean in Practice
- Non-reactive antibody: No evidence of prior HCV exposure. If you have ongoing risk factors, periodic rescreening is appropriate.
- Reactive antibody + detectable RNA: Active HCV infection. Treatment is recommended.
- Reactive antibody + undetectable RNA: Prior exposure, but no current active infection. Confirm with your provider.
LifeLine Health’s clinical team walks you through your results personally — not through an automated portal message. You’ll know exactly what your results mean and what, if anything, comes next.
Pre-Treatment Evaluation: What Happens Before You Start Medication
Before prescribing treatment, your provider needs a clearer picture of your liver’s current condition and your overall health. This evaluation typically involves:
- Genotype testing: HCV has multiple genetic variants (genotypes 1 through 6). Identifying your genotype helps select the most appropriate treatment regimen, though many modern medications work across multiple genotypes [source:8].
- Liver fibrosis assessment: Your provider will want to estimate how much scarring (fibrosis) has accumulated in your liver. This can often be assessed non-invasively through blood-based scoring systems like the FIB-4 index or through imaging [source:9].
- Baseline labs: A complete metabolic panel, complete blood count, and kidney function tests help ensure the chosen medication is appropriate for your body.
- Review of other medications: Some HCV treatments interact with other drugs. Your provider will review everything you take to avoid conflicts.
This evaluation happens as part of your telehealth visits with LifeLine Health. Lab work can typically be coordinated through community-based collection sites, so you still don’t need to travel far from home.
Modern Hepatitis C Treatment: Direct-Acting Antivirals
The treatment landscape for Hepatitis C changed dramatically in the early 2010s with the development of direct-acting antivirals (DAAs) — oral medications that target specific proteins the virus needs to replicate. Before DAAs, treatment involved weekly injections of interferon with significant side effects and cure rates well below 50 percent. That era is over.
Current DAA regimens achieve sustained virologic response (SVR) rates — the clinical definition of cure — exceeding 95 percent in most patient populations [source:10]. Treatment typically lasts 8 to 12 weeks depending on the specific regimen, your genotype, the degree of liver fibrosis, and whether you’ve been treated before [source:8]. Most people tolerate these medications well. Common side effects, when they occur, tend to be mild: headache, fatigue, or nausea that resolves as treatment continues.
SVR means that HCV RNA is undetectable in your blood 12 weeks after completing treatment. At that point, the virus is considered eliminated. The liver can begin to recover, and the long-term risks of cirrhosis, liver failure, and liver cancer associated with chronic HCV infection decrease substantially [source:10].
What Treatment Looks Like Through LifeLine Health
Through LifeLine Health Tennessee’s Hepatitis C testing and treatment program, your prescribing provider conducts visits via telehealth. Medication is coordinated through the program at no cost to you. You take a once-daily pill at home — there are no injections, no weekly clinic visits, and no complicated schedules for most regimens.
Your care team stays in contact throughout treatment to check in on how you’re feeling, address any questions, and confirm you’re on track. This isn’t a system where you receive a prescription and disappear into the void until your follow-up appointment.
Follow-Up Care and Confirming Cure
Completing your medication course is not the final step. Confirming that treatment worked requires a specific follow-up test.
The standard measure of cure is an HCV RNA test drawn 12 weeks after your last dose of medication. This is called the SVR12 test. An undetectable result at that point is considered a cure by current clinical standards [source:8]. Some providers also test at 24 weeks (SVR24), though SVR12 is the more widely used benchmark.
If you have advanced liver fibrosis or cirrhosis, ongoing monitoring of liver health continues even after achieving SVR. Eliminating the virus reduces risk significantly, but people with established cirrhosis remain at elevated risk for hepatocellular carcinoma (liver cancer) and need periodic surveillance imaging [source:9]. Your LifeLine Health provider will discuss what ongoing monitoring makes sense for your specific situation.
Reducing Reinfection Risk After Treatment
Achieving SVR means the virus has been cleared — but it does not create immunity. HCV reinfection is possible if exposure occurs again after cure [source:1]. This is not a reason to avoid treatment; eliminating an active infection is always beneficial. It is a reason to think practically about risk reduction going forward.
Strategies that meaningfully reduce reinfection risk include:
- Never sharing injection equipment: Using a new, sterile syringe and needle for each injection is the single most effective way to prevent bloodborne transmission [source:1].
- Accessing syringe services programs (SSPs): These programs provide sterile equipment and often connect people to other health services including HCV testing and treatment.
- Medication-assisted treatment (MAT): For people with opioid use disorder, medications like buprenorphine or methadone reduce injection frequency and associated transmission risk [source:11].
- Regular rescreening: People with ongoing risk factors should be rescreened for HCV periodically after cure, so that any reinfection is caught and treated early [source:6].
LifeLine Health approaches these conversations without judgment. Substance use disorder is a health condition, not a moral failure, and it does not disqualify anyone from receiving HCV treatment. People who are actively using drugs can and do achieve cure, and treating HCV in this population is both clinically effective and ethically essential.
Getting Care from Knoxville and East Tennessee
LifeLine Health Tennessee does not operate a physical clinic in Knoxville — all services are delivered via telehealth, which is exactly what makes the program work for people across the state. Whether you’re in Knoxville proper, in Knox County, or in surrounding communities like Maryville, Oak Ridge, Clinton, or Sevierville, you can connect with a licensed Tennessee provider without leaving home.
What you need to get started is modest: a phone or device with internet access, a few minutes to complete an intake form, and willingness to follow up on lab work at a nearby collection site. The clinical team handles the rest — coordinating your labs, reviewing your results with you, prescribing medication if appropriate, and staying in contact throughout treatment.
East Tennessee has communities with significant rates of injection drug use and associated HCV transmission, particularly in rural and semi-rural areas where access to traditional healthcare is limited. Telehealth removes the geography barrier. It also removes the waiting-room barrier — for people who have experienced stigma in clinical settings, being able to speak with a provider from home matters.
Cost, Privacy, and the Stigma Question
No Cost, No Insurance Required
Every service LifeLine Health provides — testing, provider visits, medication, follow-up — is available at no cost to you. You do not need insurance. You do not need to qualify through an income threshold or fill out a benefits application. The program exists specifically to remove financial barriers that prevent people from getting care they need.
If you do have insurance, LifeLine Health can work with it — but having no insurance is not a problem here. It is, frankly, the situation many of the people this program was built for are in.
Confidentiality
Your health information is protected under federal privacy law (HIPAA). LifeLine Health does not share your information with employers, family members, or anyone outside your direct care team without your explicit consent. Testing and treatment records are handled with the same confidentiality as any other medical care.
If you have specific concerns about privacy — for example, if you share a household with someone and are worried about mail or phone calls — bring those concerns up when you reach out. The care team can discuss how to handle communication in a way that works for your situation.
About Stigma
Hepatitis C carries stigma that prevents many people from getting tested in the first place. The association between HCV and injection drug use — while epidemiologically real — has led to a culture of shame around the diagnosis that has no medical basis and no place in healthcare. People contract HCV through a wide range of circumstances, and regardless of how transmission occurred, the virus responds to the same treatment.
LifeLine Health’s care model is built around the understanding that stigma is a barrier to health outcomes, not a motivator for behavior change. You will not be lectured, judged, or made to feel that you need to justify your history before receiving care. That’s not a marketing claim — it’s how the program operates.
Frequently Asked Questions
Do I need a referral to access LifeLine Health’s Hepatitis C services?
No. You can contact LifeLine Health directly without a referral from another provider. The intake process starts with reaching out through their contact page, and the care team takes it from there.
How long does the entire process take from first contact to starting treatment?
Timelines vary depending on lab scheduling and individual clinical factors, but many people move from initial contact to starting medication within a few weeks. The care team will give you a realistic picture of the timeline once your intake is complete.
Can I get treated if I’m still using drugs?
Yes. Active drug use is not a barrier to HCV treatment at LifeLine Health. Current clinical guidelines support treating HCV in people who use drugs, and research shows treatment outcomes are comparable to those in people who do not use drugs [source:11]. Reinfection risk is addressed through education and harm reduction support, not by withholding treatment.
What if I was treated for Hepatitis C before and I’m worried it’s back?
If you completed treatment in the past, you should have had a follow-up RNA test to confirm SVR. If you’re unsure whether you achieved cure, or if you’ve had new risk exposures since treatment, a new HCV RNA test can clarify your current status. Reach out to LifeLine Health and describe your situation — the team can advise on what testing makes sense.
I’m pregnant and live in East Tennessee. Can I still access these services?
Pregnant women with HCV should discuss treatment timing with a provider, as some medications are not currently recommended during pregnancy [source:6]. LifeLine Health can provide testing and connect you with appropriate guidance. The CDC recommends HCV screening during each pregnancy, so knowing your status is a meaningful first step regardless of timing.
What if my antibody test comes back reactive but I feel completely fine?
That’s entirely consistent with how HCV typically behaves. A reactive antibody test means your body has been exposed to the virus. The next step is an RNA test to determine whether you have an active infection. Feeling healthy does not change the interpretation of a reactive antibody result — it just means the virus hasn’t produced noticeable symptoms yet, which is common [source:3].
Take the Next Step Toward Knowing Your Status
Hepatitis C is curable. The medication works, the process is manageable, and the care is available at no cost to you — right now, for Knoxville and East Tennessee residents. The hardest part for most people is making the first contact.
If you’re ready to get tested, have questions about your results, or want to understand whether treatment is right for your situation, send LifeLine Health a message. The intake team will respond and help you figure out the next step. There’s no commitment required to start a conversation, and everything you share is confidential.
You can also learn more about what the program includes by visiting the Hepatitis C testing and treatment page.